Daily Archives: November 5, 2018

Altus Group Launches Next Generation Software Platform ARGUS Cloud and Web Application ARGUS Acquire to Enhance Investment Performance for Commercial Real Estate Industry

ARGUS Cloud to power new web-based applications, increase user collaboration and improve ability to leverage CRE data

TORONTO, Nov. 05, 2018 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate (“CRE”) industry, announced today the launch of ARGUS Cloud and ARGUS Acquire. ARGUS Cloud is a cloud-based platform for CRE asset and investment management that leverages functionality and data from industry-leading ARGUS solutions to enhance decision-making and portfolio transparency. ARGUS Acquire is the first of several integrated web-based applications to be powered on the ARGUS Cloud platform.

ARGUS Cloud enables greater collaboration and streamlines workflows across teams and business functions by storing all information in one centralized location. It seamlessly integrates with industry-standard ARGUS Enterprise (“AE”), delivering greater value to users through the ability to store, backup and access ARGUS files and leverage additional Altus Group cloud solutions. The ARGUS Cloud platform will leverage the intelligence of AE to both support existing on-premise solutions and power a series of new critical web-based applications designed to better manage the challenges facing today’s CRE professionals.

ARGUS Acquire, the first in a series of new web-based applications, is a deal management solution that has been tailor-made to enable acquisitions teams to efficiently construct sound financial models, pitch winning deal strategies and meet capital deployment targets. It provides complete top-down visibility of acquisition deals and pipelines, creating greater efficiency and consistency.

“With the launch of ARGUS Cloud, we’re creating a connected ecosystem for the commercial real estate industry by delivering innovative cloud-based solutions that provide complete portfolio transparency and insights,” said Bob Courteau, Chief Executive Officer at Altus Group. “This is a key part of our product and partner strategy, and the next step in our plan to build additional integrated end-to-end solutions that will streamline business processes, leverage third-party data sources and reduce complexity within the CRE industry.”

ARGUS Cloud provides a number of key capabilities:

  • Store and back up files in the cloud – seamlessly move your organization’s models into a centralized cloud database for storage and accessibility with on-premise and web-based ARGUS applications. Users can easily audit files and maintain a secure record of changes made to any asset.
  • Access and collaborate on your files any time – access your models any time through a single-point of entry to ARGUS on-premise and web-based applications, regardless of location. Centrally located models allow users to collaborate more easily across their business and with partners which simplifies processes and ensures a consistent view of assets throughout their lifecycle.
  • Connect to the next generation of applications – use stored data and an industry-standard AE calculation engine to power the next generation of ARGUS applications, beginning with ARGUS Acquire. Cloud infrastructure allows streamlined workflows between on-premise and web-based applications and will enable users to connect to their growing CRE technology ecosystem.

For more information on ARGUS Cloud, please visit https://argus.altusgroup.com/argus-cloud/. For more information on ARGUS Acquire, please visit https://argus.altusgroup.com/argus-acquire/.

About Altus Group Limited

Altus Group Limited is a leading provider of software, data solutions and independent advisory services to the global commercial real estate industry. Our businesses, Altus Analytics and Altus Expert Services, reflect decades of experience, a range of expertise, and technology-enabled capabilities. Our solutions empower clients to analyze, gain insight and recognize value on their real estate investments. Headquartered in Canada, we have approximately 2,500 employees around the world, with operations in North America, Europe and Asia Pacific. Our clients include some of the world’s largest real estate industry participants. Altus Group pays a quarterly dividend of $0.15 per share and our shares are traded on the TSX under the symbol AIF.

For more information on Altus Group, please visit: www.altusgroup.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Altus Group Limited

Jeff Hayward
Vice President, Global Marketing & Communications
416-234-4212
jeff.hayward@altusgroup.com

Camilla Bartosiewicz
Vice President, Investor Relations
416-641-9773
camilla.bartosiewicz@altusgroup.com

StackPath Begins Providing Free Private SSL Certificates

Partnership with Sectigo (Comodo CA) helps developers secure websites and applications

DALLAS, Nov. 05, 2018 (GLOBE NEWSWIRE) — StackPath, a leading platform of secure edge services, today announced it has partnered with Sectigo, formerly Comodo CA, the global innovator of security solutions, to include private SSL certificates for no additional cost with StackPath content delivery network (CDN), web application firewall (WAF), and Edge Delivery subscriptions. StackPath customers can receive a private SSL certificate for each CDN or WAF site they create on the StackPath platform, ensuring their end users’ traffic is encrypted from the web browser to the content or web application.

“We’re on a mission to make the internet safe, and offering free SSL certificates is one of many ways we’re doing it,” said Ben Gabler, StackPath Senior VP of Product. “SSL encryption has long been expected on login forms and checkout pages, but today it’s essential to have SSL encryption for your entire website or application. It makes the internet more secure as a whole, as modern browsers warn users if an SSL certificate is not present.”

“Recently, Google began marking sites without SSL certificates as ‘not secure’, so it’s more important than ever for companies to ensure their sites are now protected,” said Tim Callan, Senior Fellow at Sectigo. “We are thrilled that our partnership with StackPath is helping make the internet safe for consumers, especially with the holiday shopping season and Black Friday right around the corner.”

The free private SSL certificates are an extension of StackPath Edge SSL suite, complementing the platform’s ability to provide shared SSL encryption or for customers to use third-party SSL certificates that they already own. StackPath Edge SSL serves the SSL certificates from StackPath edge nodes around the world, accelerating authentication, increasing end user security, and taking the burden of SSL authentication and validation off of a website, application, or cloud service’s origin servers.

New and existing StackPath customers can request their free private Edge SSL certificates through the StackPath customer portal. Private Edge SSL certificates are automatically renewed when they reach their expiration date; customers who already have third-party SSL certificates can request and use a free private Edge SSL server and no longer worry about keeping their certificates valid.

StackPath®
Protect your edge.™

StackPath is a platform of secure edge services that enables developers to protect, accelerate, and innovate cloud properties ranging from websites to media delivery and IoT services. With an innovative global edge network infrastructure, StackPath delivers enterprise-grade security and performance in a frictionless, on-demand platform with cloud-scale control and flexibility. More than one million customers, including early-stage and Fortune 100 companies, use StackPath services. StackPath is headquartered in Dallas and has offices across the U.S. and around the world. For more information, visit stackpath.com and follow StackPath at www.fb.com/stackpathllc and www.twitter.com/stackpath

For more information, media and analysts may contact:
Susie McDonald
StackPath
VP, Corporate Communications
susan.mcdonald@stackpath.com
503-806-3841

More people in Coimbatore living with kidney disease will have access to dialysis from today

Fresenius Medical Care and Sri Ramakrishna Hospital inaugurate new dialysis center of excellence in Coimbatore, India

India, Nov. 05, 2018 (GLOBE NEWSWIRE) — 2 November 2018, Coimbatore, India — Fresenius Medical Care, the world’s largest provider of dialysis products and services, in collaboration with Sri Ramakrishna Hospital, today announced the inauguration of a new dialysis center of excellence. Fresenius Medical Care and the hospital, which is a NABH (National Accreditation Board for Hospitals & Healthcare Providers) – accredited healthcare provider in Tamil Nadu state in the South of India, will provide 12 dialysis stations offering advanced dialysis therapies to help meet the growing demand for treatment in Coimbatore.

India has a high prevalence of chronic kidney disease (CKD), which is estimated to affect 17 per cent of the population.1 The rising incidence of CKD is expected to pose major problems for healthcare providers and the Indian economy in future years.2

“A recent study has shown that the number of people undergoing dialysis in India increases by 100,000 each year2. There is an urgent demand for new dialysis centers that are able to provide excellent care for more patients,” said Mr. Punit Kohli, Managing Director, Fresenius Medical Care India.

“The new center provides patients with the high standards of technology, patient comfort and highly-qualified medical staff. By working closely with Sri Ramakrishna Hospital, we have been able to build a center that is tailored to the specific needs of kidney patients in the region,” he said.

 The hospital-based center will offer a range of advanced dialysis options including high-flux hemodialysis and online hemodiafiltration (HDF). Online HDF allows better removal of waste products from the blood, contributing to improved survival for patients compared with those receiving standard hemodialysis.3,4 As part of the company’s holistic approach to patient care, the center will offer holiday dialysis, allowing patients travelling from other regions or from overseas to access uninterrupted treatment.

A ribbon-cutting ceremony on 2 November was organized to officially open the center, with Mr. Punit Kohli and Mr. D. Lakshminarayanaswamy, Joint Managing Trustee, SNR Sons Charitable Trust, officiating. The opening will bring the total number of Fresenius Medical Care dialysis centers in India to 43.

“The hospital will be able to expand its clinical versatility with this dialysis center of excellence,” said Mr. D. Lakshminarayanaswamy. ”We are proud to be collaborating with Fresenius Medical Care, a company that is committed to increasing access to dialysis care throughout Tamil Nadu, enabling people with chronic kidney disease to lead more active and fulfilling lives.”

References

  1. Varughese S, Abraham G. Chronic Kidney Disease in India. Clinical Journal of the American Society of Nephrology. 2018;13(5):802-804. Available from https://cjasn.asnjournals.org/content/early/2018/01/29/CJN.09180817#ref-4. Accessed 24 October 2018.
  2. Singh A, Farag Y, Mittal B, Subramanian K, Reddy S, Acharya V et al. Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrology. 2013;14(1). Available from https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-14-114. Accessed 24 October 2018.
  3. Maduell et al; High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients, J Am Soc Nephrol 24: 487-497, 2013
  4. Erratum. JASN May 2014, 25 (5) 1130

ABOUT FRESENIUS MEDICAL CARE

Fresenius Medical Care is the world’s largest provider of products and services for individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,872 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 329,085 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the company provides related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

For more information visit: www.freseniusmedicalcare.com

ABOUT SRI RAMAKRISHNA HOSPITAL

Sri Ramakrishna Hospital is an NABH Accredited 1000-bed hi-tech multi-specialty medical complex with almost four decades of experience in kidney care and it is situated in the heart of Coimbatore City. The hospital provides advanced technology, surgical and medical techniques and is driven by its founding ethos of providing accessible healthcare, ensuring that patients receive the very best of care at nominal cost with an excellent ambience, well trained courteous staff supported by latest in medical innovation let us make your dialysis experience enjoyable.

For more information, visit www.snrsonstrust.org, www.sriramakrishnahospital.com

DISCLAIMER

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Attachments

Dr. Alexandra Villar, Senior Director Marketing Communications
Fresenius Medical Care Asia-Pacific Limited
+61 2 9466 8020
Alexandra.Villar@fmc-asia.com

More people in Coimbatore living with kidney disease will have access to dialysis from today

Fresenius Medical Care and Sri Ramakrishna Hospital inaugurate new dialysis center of excellence in Coimbatore, India

India, Nov. 05, 2018 (GLOBE NEWSWIRE) — 2 November 2018, Coimbatore, India — Fresenius Medical Care, the world’s largest provider of dialysis products and services, in collaboration with Sri Ramakrishna Hospital, today announced the inauguration of a new dialysis center of excellence. Fresenius Medical Care and the hospital, which is a NABH (National Accreditation Board for Hospitals & Healthcare Providers) – accredited healthcare provider in Tamil Nadu state in the South of India, will provide 12 dialysis stations offering advanced dialysis therapies to help meet the growing demand for treatment in Coimbatore.

India has a high prevalence of chronic kidney disease (CKD), which is estimated to affect 17 per cent of the population.1 The rising incidence of CKD is expected to pose major problems for healthcare providers and the Indian economy in future years.2

“A recent study has shown that the number of people undergoing dialysis in India increases by 100,000 each year2. There is an urgent demand for new dialysis centers that are able to provide excellent care for more patients,” said Mr. Punit Kohli, Managing Director, Fresenius Medical Care India.

“The new center provides patients with the high standards of technology, patient comfort and highly-qualified medical staff. By working closely with Sri Ramakrishna Hospital, we have been able to build a center that is tailored to the specific needs of kidney patients in the region,” he said.

 The hospital-based center will offer a range of advanced dialysis options including high-flux hemodialysis and online hemodiafiltration (HDF). Online HDF allows better removal of waste products from the blood, contributing to improved survival for patients compared with those receiving standard hemodialysis.3,4 As part of the company’s holistic approach to patient care, the center will offer holiday dialysis, allowing patients travelling from other regions or from overseas to access uninterrupted treatment.

A ribbon-cutting ceremony on 2 November was organized to officially open the center, with Mr. Punit Kohli and Mr. D. Lakshminarayanaswamy, Joint Managing Trustee, SNR Sons Charitable Trust, officiating. The opening will bring the total number of Fresenius Medical Care dialysis centers in India to 43.

“The hospital will be able to expand its clinical versatility with this dialysis center of excellence,” said Mr. D. Lakshminarayanaswamy. ”We are proud to be collaborating with Fresenius Medical Care, a company that is committed to increasing access to dialysis care throughout Tamil Nadu, enabling people with chronic kidney disease to lead more active and fulfilling lives.”

References

  1. Varughese S, Abraham G. Chronic Kidney Disease in India. Clinical Journal of the American Society of Nephrology. 2018;13(5):802-804. Available from https://cjasn.asnjournals.org/content/early/2018/01/29/CJN.09180817#ref-4. Accessed 24 October 2018.
  2. Singh A, Farag Y, Mittal B, Subramanian K, Reddy S, Acharya V et al. Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrology. 2013;14(1). Available from https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-14-114. Accessed 24 October 2018.
  3. Maduell et al; High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients, J Am Soc Nephrol 24: 487-497, 2013
  4. Erratum. JASN May 2014, 25 (5) 1130

ABOUT FRESENIUS MEDICAL CARE

Fresenius Medical Care is the world’s largest provider of products and services for individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,872 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 329,085 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the company provides related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

For more information visit: www.freseniusmedicalcare.com

ABOUT SRI RAMAKRISHNA HOSPITAL

Sri Ramakrishna Hospital is an NABH Accredited 1000-bed hi-tech multi-specialty medical complex with almost four decades of experience in kidney care and it is situated in the heart of Coimbatore City. The hospital provides advanced technology, surgical and medical techniques and is driven by its founding ethos of providing accessible healthcare, ensuring that patients receive the very best of care at nominal cost with an excellent ambience, well trained courteous staff supported by latest in medical innovation let us make your dialysis experience enjoyable.

For more information, visit www.snrsonstrust.org, www.sriramakrishnahospital.com

DISCLAIMER

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Attachments

Dr. Alexandra Villar, Senior Director Marketing Communications
Fresenius Medical Care Asia-Pacific Limited
+61 2 9466 8020
Alexandra.Villar@fmc-asia.com